Physician profile
Devika R Patel
NPI 1427549393
$1,497.30
in general payments reported to CMS, 2019-2025
17 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.79 · 2022: $505 · 2023: $301 · 2024: $374 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $412.76 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $295.30 | 2022-2025 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $278.75 | 2022-2025 | Caplyta |
| Neuronetics, INC. | $75.82 | 2022-2023 | Neurostar Tms Therapy System |
| Idorsia Pharmaceuticals US INC | $72.76 | 2023-2024 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $60.51 | 2025 | Austedo Xr |
| Corium, LLC | $56.89 | 2022-2024 | Azstarys |
| Sunovion Pharmaceuticals INC. | $54.00 | 2022 | |
| Alkermes, INC. | $38.84 | 2022 | |
| Orexo US, INC. | $34.84 | 2021-2022 | |
| Indivior INC. | $19.97 | 2023 | Sublocade |
| Neos Therapeutics, LP | $19.53 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.89 | 2025 | Trintellix |
| Axsome Therapeutics, INC. | $16.85 | 2024 | Auvelity |
| Tris Pharma INC | $14.40 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.17 | 2022 | |
| Lundbeck LLC | $14.02 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devika Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.